This review offers a framework for Medicaid programs to broadly assess cell and gene therapies, evaluate payment options, and ensure equitable access. Share: Previous Post Systemic Corticosteroids to Prevent Bronchopulmonary Dysplasia Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines Screen Time and Parent-Child Talk During the Early Years Clinical Practice Guidelines Physical Activity and Mental Health in Children and Adolescents With Neurodevelopmental Disorders Clinical Practice Guidelines Association Between Funding and School Suspension Rates for Autistic Students in New Zealand Clinical Practice Guidelines Social Interventions and Health Care Utilization for Child Asthma Clinical Practice Guidelines Timing of Allergenic Food Introduction and Risk of Immunoglobulin E–Mediated Food Allergy Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.